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Retroviral replication leaves a DNA copy in the host cell chromosome, which over
millions of years of infection of germline cells has led to 5% of the human genome
sequence being comprised of endogenous retroviruses (ERVs), distributed throughout
an estimated 100,000 loci. Over time these loci have accrued mutations such as
premature stop codons that prevent continued replication. However, many loci remain
both transcriptionally and translationally active and ERVs have been implicated in
interacting with the host immune system. Using archived plasma and tissue samples
from past macaque studies, experimentally infected with simian immunodeficiency virus
(SIV), the expression of one macaque ERV in response to acute viral infection was
explored together with a measure of the innate immune response. Specifically, RNA
levels were determined for (a) Papio cynocephalus Endogenous Retrovirus (PcEV), an
ERV (b) STAT1, a key gene in the interferon signaling pathway, and (c) SIV, an exogenous
pathogen. Bioinformatic analysis of DNA sequences of the PcEV loci within the macaque
reference genome revealed the presence of open reading frames (ORFs) consistent with
potential protein expression but not ERV replication. Quantitative RT-PCR analysis of
DNase-treated RNA extracts from plasma derived from acute SIV-infection detected
PcEV RNA at low levels in 7 of 22 macaques. PcEV RNA levels were significantly elevated
in PBMC and spleen samples recovered during acute SIV infection, but not in the thymus
and lymph nodes. A strong positive correlation was identified between PcEV and STAT1
RNA levels in spleen samples recovered from SIV-positive macaques. One possibility is
that SIV infection induces PcEV expression in infected lymphoid tissue that contributes
to induction of an antiviral response.
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INTRODUCTION
Endogenous Retroviruses (ERV) are descendants of ancient
retroviral infections that have become established in the
germline and proliferated to now represent ∼5% of the human
genome and other mammals, rising to ∼8% if the older
group of Mammalian Apparent LTR-Retrotransposons (MaLRs)
are included. Individual proviruses, termed loci, accumulate
mutations over time during their Mendelian transmission that
eventually render them replication-defective. In the human
reference genome, no locus has retained full-length Open
Reading Frames (ORFs) for all genes which precludes the
possibility of yielding infectious, cell-free progeny virions (1, 2).
However, ERVs and other retroelements have been shown to play
a role in epigenetic gene regulation (3–7), with many ERV loci
having been co-opted. Examples include HERV-E Long Terminal
Repeat (LTR)-driven tissue-specific expression of a human
salivary amylase gene (8), ERV-derived syncytins that play a role
in placentation (9), and promoter-containing LTRs of ERVs that
influence epigenetic gene control and pluripotency (10).
The study of ERVs in non-human primates (NHP) has
potential to broaden the wealth of data generated from mouse
studies. Smaller mammals tend to havemore ERV loci integrating
into their genome than larger mammals (11) and, consistent
with this general pattern, replication-competent ERV loci have
been found in the mouse (12) but not in humans (1, 2, 12–
14). In terms of the number of recently integrated ERV loci,
the macaque genome is more similar to the human than the
mouse (11). Macaques thus represent an opportunity to derive
additional relevant data that could augment more conventional
mouse studies. To help bridge this gap we have utilized archived
materials derived from previous simian immunodeficiency virus
(SIV) studies.
Recently, it has been suggested ERVs and other retroelements
play a role in innate immune signaling by acting as Pathogen
Associated Molecular Patterns (PAMPs) (15–21). Indeed, it has
been proposed that retroelement PAMPs, such as cytosolic
DNA resulting from reverse transcription, set an activation
threshold for triggering the innate immune response (22). These
authors speculate that the level at which activation occurs is
an evolutionary trade-off between avoidance of tolerance of
exogenous pathogens on one hand and constant triggering
by endogenous elements on the other. The latter appears to
occur in the inherited autoimmune disease Aicardi-Goutieres
syndrome where deficiency of TREX1 DNA endonuclease may
lead to a build-up of retroelement PAMPS, which triggers
inappropriate innate signaling (23). If ERVs were involved in the
early immune response, it might be expected that a correlation
would exist between ERV expression and measures of innate
immune activation in archived macaque samples taken during
acute infection.
Our study focuses on Papio cynocephalus Endogenous
Retrovirus (PcEV), a recently integrated ERV first described in
baboons (24). PcEV is one of three ERV lineages copying within
the macaque genome during the last 5 million years (25). Since a
range of components in the ERV replication cycle can potentially
be detected by the innate immune system (26), we argue that the
likelihood of an ERV locus being biologically relevant increases if
its sequence is free of inactivating mutations such as premature
stop codons. Induction of type-1 interferons (IFN-1), via the
JAK/STAT pathway, represents a key part of the innate response
to viral infections (27, 28). Interferon-stimulated genes (ISGs)
act to limit viral replication and play a role in the control of
the viral burden (29). However, the immunomodulatory role
of ISG induction in acute-phase and chronic SIV infection is
complex and relatively poorly understood, contributing to both
dampening and inflammatory immune responses (30, 31). IFN-
1 signaling results in the transcription of hundreds of ISGs, an
important member being STAT1 (32, 33). Basal IFN-1 levels
set the abundance of STAT1, which influences the susceptibility
toward infection (34). STAT1 therefore provides a measure of
IFN-1 activation induced during acute SIV infection in macaques
(35), hence its expression was explored in this study.
Archived macaque plasma and tissue samples were analyzed
to determine PcEV activity during acute SIV infection when de
novo responses are likely to be highest, particularly lymphoid
tissues targeted during primary infection (35). This activity
was also compared with STAT1 RNA levels in the same RNA
preparations. Our study represents the first analysis of PcEV loci
in the macaque reference genome sequences and demonstrates
the presence of multiple potentially protein-coding, but not
replicating, PcEV loci. In conjunction with identification of low
levels of PcEV RNA in plasma of a proportion of acutely SIV-
infected macaques, PcEV was actively transcribed in tissues with
a level of cell-associated gene expression that is upregulated in
response to acute SIV infection. In the spleen, this appeared to
be directly correlated to STAT1 RNA expression. The potential
significance of these findings linking ERV and innate immunity
are discussed.
RESULTS
Bioinformatic Analysis Suggests PcEV
Protein Production but Not Replication
An online search of the most recent rhesus macaque (Macaca
mulatta, RM) genome assembly (rheMac8) using the constructed
PcEV reference sequence revealed 72 PcEV loci (plus another 76
matches in unassembled regions), most of which are represented
only by fragments. Figure 1 illustrates the only 10 loci that do
not have large regions (more than a few hundred nucleotides)
missing from the reference genome. Among these loci are
examples of full-length ORFs for all genes but no single locus has
full-length ORFs in all genes.
The fragmentation observed is largely the result of genome
assembly errors. Four of these 10 most intact loci contain
scaffold gaps, where sequenced regions either side have not been
joined. One example is locus chr9:50301533-10531, which in
the rheMac8 assembly has its pro-pol reading frame interrupted
by a single premature stop codon and by a long insertion
which consists of a tandem duplication at a region marked as
a scaffold gap. However, an examination of this locus sequence
from an earlier assembly of the RM genome (rheMac2), which
was from the same individual animal, and from the homologous
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FIGURE 1 | PcEV loci with full-length ORFs for some but not all genes. Premature stop codons are shown as asterisks and frame-shifting (or large in-frame) indels are
shown by the number of nucleotides involved (“H” marks an indel within a homopolymer, assumed to be sequencing errors). Results are from the rheMac8 build with
all interruptions either confirmed or corrected using the earlier rheMac2 build from the same animal, i.e., interruptions were treated as sequencing errors if present only
in one build. Details of assembly problems in these loci are in Supplementary Information, which also contains multiple alignments for the three genes, the LTR
alignments used for dating, the flanking regions used to determine locus homology across genomes, and reference (consensus) sequences both for the complete
provirus and individual genes. Pro-pol alignment starts from the position suggested in Mang et al. (24). The reference coordinates here include a one nucleotide gap
inserted at the end of pro-pol to incorporate the frameshift in env. Note, the gag and pro-pol are translated in the same frame with suppression of the gag stop
codon (36).
locus in the cynomolgus macaque (Macaca fascicularis, CM)
genome (macFas5), a species that diverged from the RM ∼1–
2 million years ago (mya) (37, 38), demonstrates that neither
the premature stop codon nor the insertion belong to this locus.
These three pro-pol sequences are not homologous along their
entire length and have a clearly visible transition, a “breakpoint,”
near to position 3,937 in the reference genome: the ∼40% of
the rheMac8 pro-pol sequence before this breakpoint is no more
similar to the other two sequences than it is to a range of other
PcEV loci, while downstream the sequences of all three loci are
very similar.
This can also be demonstrated phylogenetically (Figure 2),
where a tree of pro-pol sequences before the breakpoint shows
the rheMac8 sequence is not recovered in the same clade as
the rheMac2 and macFas5 sequences, while a tree of the pro-
pol sequences after this break-point shows all three sequences
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recovered together in a well-supported clade (as seen in the other
loci). This represents a clear assembly error. Indeed, the locus
in rheMac2 and in macFas5 are in the antisense direction while
the locus in rheMac8 is in the sense direction. Consistent with
widespread assembly problems, only approximately half of the
’intact’ loci in rheMac8 are intact in macFas5, and vice versa.
There is also much more fragmentation in PcEV loci than in
the human HERV-K(HML2) loci (39), which belong to an older
ERV lineage (40). The human ERVs were only sequenced after
being cloned within bacterial artificial chromosomes (41), which
avoided the problem with the macaque genomes of trying to
assemble simultaneously multiple very similar ERV loci from
short next generation sequencing reads.
Evidence was identified of insertionally polymorphic PcEV
loci, i.e., loci present in some individuals but not others
(42). The intact loci recovered are mostly several millions
of years old (Figure 1), the most recently integrated locus
being chr9:50301533-10531. The LTRs of this locus differ by
two substitutions which, given an estimated rate of nucleotide
substitution of ∼1 × 10−9/nucleotide/year (25), indicates an
age of ∼1.9 million years. All these loci are also found in the
CM reference genome and are therefore expected to be fixed
in the RM population. However, two loci with large scaffold
gaps were estimated to have integrated within at least the
last 700,000 years; both were insertionally polymorphic. Locus
chr1:55452680-60247 is heterozygous for presence/absence
(=provirus/pre-integration site) in the reference genome and
locus chr5:114918771-21894 is represented solely by the pre-
integration site in the rheMac3 genome sequence, which is from a
different individual (from China rather than India; further details
of these loci are included in Supplementary Information).
We infer from these observations that PcEV transcription
arising from some of these 10 loci may result in PcEV protein
production but is unlikely to result in PcEV replication.
PcEV Loci Are Likely to be Transcribed and
Lack STAT1 Binding Sites
The LTRs of the above loci, excluding the two very old ones,
all have an undisrupted TATA binding protein (TBP) binding
site (=TATA box) at position 382 (Figure 3; Table S1). This
correlates to the position of the conserved TATA box found
in PcEV in the baboon genome (24). Since the TATA box
usually has at least minimal promoting activity (43), loci without
disruption in the TBP binding site are likely to be transcribed.
Another TBP binding site was predicted at position 51 but
is unlikely to be real since it is poorly conserved among the
loci and not found in other γ-retroviruses, such as HERV-W
and MuLV (43, 44). The LTRs also contain many undisrupted
transcription factor binding sites. The regions containing these
sites correlated with ones already described in the baboon (24),
so were named in accordance with that earlier study. Direct-
repeat enhancers (DR1, DR2, DR3) contained sites for GRα,
GATA1, and GATA2. Three CCAAT box-associated binding
regions (CCAAT box 1, 2, and 3) contained sites for GRβ, CEBPβ,
and NFY. A fourth CCAAT box region (box 4) contains these
three sites plus the site for CEBPα. Such CCAAT boxes directly
upstream of a TATA box have been shown to efficiently promote
transcription activity of the HERV-W LTR (43). Other retroviral
LTRs similarly harbor binding sites for many transcription
factors (45).
The screening of PcEV loci for putative transcription factor
binding sites included key inflammation-related transcription
factors: STAT1, NFκB (46), and STAT3 (47). Predicted binding
sites for STAT1 and NFκB were not identified, so it is
therefore unlikely that STAT1 or NFκB directly regulates PcEV
expression through binding to the retroviral promoter. The only
inflammation-related transcription factor binding site found was
for STAT3 at position 149 (Figure 3).
Low Levels of Plasma PcEV RNA in
One-Third of Acutely SIV-infected
Macaques
Cell-free PcEV RNA levels were measured by RT-qPCR in
plasmas from unchallenged control (naïve) macaques (n = 5)
or macaques at or around peak SIV viraemia (SIV+) challenged
with one of four different SIV strains; SIVmac239 (n = 5),
SIVmac251 (n = 5), SIVmacC8 (n = 6), or SIVsmE660 (n =
6). SIVmacC8 represents a minimally attenuated nef -disrupted
variant of wild-type SIVmac251/32H (35), while all others are
wild-type SIVs belonging to the SIVmac/SIVsm lineage. All
viral challenges were performed in CM, except for SIVmac239
conducted in RM. Three naïve animals were CM, two were RM.
As shown in Figure 4, 7 of 22 macaques (32%) exhibited low
but detectable levels of PcEV in their plasma (39; 84; 94; 139;
70; 35; 165 PcEV copies/ml). These seven macaques include
instances of infection with each of the four SIV strains. PcEV
RNAwas not detected in the plasma of naïve macaques, although
the small sample size does not enable any inference about the
relationship between PcEV detection in plasma and SIV status
(Fisher’s Exact Test comparing presence vs. absence of PcEV
in plasma, from naïve and pooled SIV+ macaques, p=0.27).
Stringent protocols were employed for DNase treatment to
remove contaminating genomic DNA, including paired +/– RT
reaction steps in each experiment (Figure S1). Neither PcEV nor
SIV were amplified in RT minus reactions (Table 1), providing
additional confidence that all PcEV molecules originated from
an RNA template. Hence, low but detectable PcEV RNA
was detectable in around one-third of SIV+ plasmas during
acute infection.
Variable Baseline Tissue PcEV
Transcriptional Activity Is Upregulated
During Acute SIV Infection
Levels of detectable cellular PcEV transcripts in a range of
tissues targeted by SIV were determined, isolating RNA from
PBMC, spleen, thymus, peripheral and mesenteric lymph nodes
(PLN/MLN) from naïve and acutely SIV+ macaques. Data
generated for cell-associated PcEV transcriptional activity were
compared for each preparation, normalized by co-amplification
of the constitutively expressed cellular GAPDH gene with PcEV.
Baseline PcEV RNA transcriptional activity was identified in
the majority of tissues from all naïve macaques (Figure 5),
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FIGURE 2 | Example of assembly error in reference genome. Reconstruction of the locus chr9:50301533-10531 using homologous sequences in the 2 RM genome
assemblies (rheMac8 and rheMac2) and in the CM genome (macFas5). See Figure 1 legend for annotation of ORFs. Loci shown are those in Figure 1 (a/b = locus
on chromosome with lower/higher coordinate value). Phylogenetic trees were built using NJ in MEGA from the 501 to 1,397 and the 1,398 to 2,607 regions of the
pro-pol alignment, with sequences from this locus shown in red. Values below branches are bootstrap score (1,000 replicates).
though many were at low levels and none exceeded 60 PcEV
RNA copies/1,000 copies GAPDH. In these naïve tissues,
basal PcEV transcriptional activity for MLN, thymus, PBMC,
spleen and PLN was determined as 19, 20, 25, 33, and 52
PcEV RNA copies/ml, respectively. Differences between these
tissue means were not statistically significant (Kruskal-Wallis
test, p= 0.07).
Mean PcEV levels were higher in tissues recovered from
SIV+ macaques during acute infection (10–14 days post-
infection) compared to naïve macaques (Figure 5). PcEV RNA
was significantly increased in PBMC (Mann-Whitney test, p
= 0.01) and thymus (p = 0.03), but increases were not
significantly different in spleen (p = 0.23), MLN (p = 0.38),
and PLN (p = 0.20). Differences between tissue means were
not statistically significant (Kruskal-Wallis test, p = 0.83). Taken
together, the data indicate that SIV infection per se upregulates
the expression of PcEV RNA from a variable baseline level of
transcriptional activity in a range of tissues targeted by SIV
during acute infection.
Cellular STAT1 RNA Levels Are Elevated
During Acute SIV Infection
STAT1 represents an independent variable in these studies and
its relationship with SIV status and tissue type was determined
in the same manner as for PcEV (Figure 6). As with PcEV, a
global STAT1 induction was observed during acute SIV infection
compared to naïve macaques. Considering each tissue separately,
STAT1was significantly increased in PBMC (Mann-Whitney test,
p < 0.001), thymus (p < 0.001), and MLN (p = 0.03), but not
spleen (p = 0.15) or PLN (p = 0.60). Hence, during acute SIV
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FIGURE 3 | PcEV LTR TATA box and transcription factor binding sites. Prediction of transcription factor binding sites and TATA box in the eight PcEV loci described in
the macaque genome in this study. LTR sequences from PcEV loci in the baboon (accessions NC_022517 and AF142988) are also shown.
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FIGURE 4 | Low levels of PcEV RNA are present in the plasma of some SIV+
macaques. Viral RNA copies/ml plasma RNA in naïve and SIV+ macaques:
SIVmac239 (48), SIVmacC8 (35), SIVmac251 (49), and SIVsmE660 (50).
Absence of DNA contamination was confirmed in all experiments by
simultaneous RT-qPCR without the RT enzyme and only results from the
corresponding RT+ reactions are shown. Each symbol represents the number
of RNA copies from a single individual; open circles denote PcEV, closed
circles SIV.
infection cellular STAT1 levels are elevated, though at variable
levels for individual tissues, as SIV infection stimulates a robust
immune response.
Cell-Associated PcEV Transcription Levels
Are Correlated to STAT1 in SIV+ Spleens
Finally, expression levels of the two genes were compared in the
same RNA preparations from each tissue sample. Figure 7 shows
tissue-specific patterns identifying the relationship between
localized PcEV and STAT1 expression. Cellular PcEV and STAT1
RNA levels were strongly correlated in the spleen of SIV+
macaques (Spearman test, r = 0.90, p = 0.005) and showed
a positive though statistically non-significant relationship in
spleens derived from naïve macaques (r = 0.68, p = 0.11).
Two SIV+ macaques (H19 and H20) with elevated splenic
PcEV levels were PcEV+ in plasma, but the macaque with
the highest level (G24) was PcEV RNA- in plasma. Four
PBMC samples from macaques that were PcEV+ in plasma
(including H19 and H20) exhibited a wide range of PcEV
transcription levels.
STAT1 and PcEV levels were not significantly correlated in
the other tissues but most relationships were positive. Pooling all
tissue data from the 22 SIV+ macaques (a total of 30 samples)
yielded a strong positive correlation (Spearman test, r = 0.47;
p = 0.0091). Pooled PcEV and STAT1 levels in the 13 naïve
macaques were also strongly correlated (r = 0.61; p = 0.0004),
albeit at a lower magnitude of induction for both PcEV and
STAT1. Such correlations in pooled data might be artifactual
but it is interesting that no such correlation was found between
STAT1 and cellular SIV levels in these total RNA preparations
(r = 0.29, p= 0.21); there was also no correlation between STAT1
and plasma SIV RNA levels (r = 0.25, p= 0.22).
TABLE 1 | PcEV and SIV RNA levels in plasma as determined by qPCR with (+)
and without (–) reverse transcriptase (RT).
PcEV RNA copies/ml SIV RNA copies/ml
SIV strain Individual RT+ RT- RT+ RT-
Naïvea E79 No Ct No Ct No Ct No Ct
E80 No Ct No Ct No Ct No Ct
E81 No Ct No Ct No Ct No Ct
SIVmac239a E79 No Ct No Ct 2.60 × 106 No Ct
E80 No Ct No Ct 7.24 × 105 No Ct
E81 No Ct No Ct 4.23 × 106 No Ct
SIVmacC8a E5 No Ct No Ct 1.04 × 105 No Ct
E6 No Ct No Ct 2.03 × 104 No Ct
G3 39 No Ct 4.01 × 104 No Ct
G4 No Ct No Ct 4.75 × 104 No Ct
G5 No Ct No Ct 5.14 × 103 No Ct
G6 No Ct No Ct 2.31 ×104 No Ct
SIVmac251a J41 No Ct No Ct 1.42 × 105 No Ct
J42 No Ct No Ct 9.35 × 104 No Ct
J44 84 No Ct 4.29 × 105 No Ct
J17 No Ct No Ct 7.22 × 103 No Ct
J18 94 No Ct 1.29 × 104 No Ct
SIVsmE660a G25 No Ct No Ct 2.25 × 107 No Ct
G26 139 No Ct 3.13 ×105 No Ct
G27 No Ct No Ct 2.12 × 107 No Ct
G28 No Ct No Ct 3.97 × 107 No Ct
G7 70 No Ct 9.91 × 107 No Ct
G8 No Ct No Ct 2.89 ×107 No Ct
Naïveb H17 No Ct No Ct No Ct No Ct
H18 No Ct No Ct No Ct No Ct
SIVmac239b H19 37 No Ct 3.64 × 105 No Ct
H20 165 No Ct 2.52 × 105 No Ct
Species of macaque is indicated; CM, cynomolgusmacaque; RM, rhesusmacaque. PcEV
RNA levels are expressed as simple integers; SIV RNA levels use a power of ten notation.
Ct, cycle threshold.
a In CM.
b In RM.
DISCUSSION
The transcriptional activity of an ERV in macaques has been
investigated using a combination of bioinformatic prediction
analyses and biological measures of in vivo activity, exploiting
archived biological materials collected from previous macaque
challenge studies. PcEV expression was upregulated in several
key lymphoid tissues of acutely SIV-infected macaques, when de
novo immune responses are likely to be highest. In the spleen
PcEV expression was positively correlated to cellular STAT1 RNA
levels. Analysis of baseline data indicated low, variable cell-
associated PcEV RNA levels in the absence of a clear external
stimulus, such as SIV. Introduction of SIV induced PcEV in all
tissues measured, attaining statistical significance in the thymus
and PBMC. While caution needs to be exercised in not over-
interpreting our findings given a number of caveats (e.g., inherent
variations in SIV strain dynamics, tissues targeted during acute
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FIGURE 5 | SIV infection upregulates PcEV expression. Comparison of PcEV
expression in PBMC, spleen, thymus, MLN, and PLN. Open symbols
represent naïve macaques and closed symbols represent SIV+ macaques.
Each symbol represents the number of PcEV RNA copies from a single tissue
from a single individual. Means for each group are indicated as horizontal bars
with p-values given from a Mann-Whitney comparison of the ranked
expression levels between naïve and SIV+ macaques.
FIGURE 6 | STAT1 is upregulated in acute SIV infection. Comparison of STAT1
copies in PBMC, spleen, thymus, MLN, and PLN. Open symbols represent
naïve macaques and closed symbols represent SIV+ macaques. Each symbol
represents the number of PcEV RNA copies from a single tissue from a single
individual. Means for each group are indicated as horizontal bars with p-values
given for a Mann-Whitney comparison of the ranked expression levels
between naïve and SIV+ macaques.
infection, macaque species), these data clearly suggest a global
upregulation of PcEV transcriptional activity in response to acute
SIV infection.
It is widely recognized that SIV establishes productive
infection in multiple lymphoid tissues during the primary
viraemic phase. STAT1, part of the IFN-1 cascade, represents one
component of the dynamic response to SIV, triggering a range
of innate immunity genes during acute infection (35), but this
response fails to clear the virus in the long term. This study
confirmed induction of STAT1, part of the IFN-1 cascade in
response to SIV, highlighting tissue-specific differences. In the
spleen, PcEV and STAT1 RNA levels were positively correlated
but this relationship was less clear in PBMC, thymus and MLN
andwarrants further scrutiny, especially where small sample sizes
precluded a comprehensive analysis.With both PcEV and STAT1,
exposure to SIV per se appears sufficient to trigger a response
independent of the level of viral replication.
Although little is known about the macaque, in the mouse
model it is well-established that microbial triggering of innate
and adaptive sensors leads to increased ERV transcription
(51). Treatment with both lipopolysaccharide (LPS), a Toll-like
receptor 4 (TLR4) agonist, and polyinosinic-polycytidylic acid
[poly(I:C)], a TLR3 agonist, significantly induced expression of
two mouse ERV proviruses (52). Examples of human ERVs
whose expression is enhanced in the presence of IFN or viral
infection include HERV-K(HML2), reported to be increased
in PBMC from HIV-1-infected individuals (13, 53, 54), and
HERV-W was reported to be increased by influenza virus
infection in vitro (55, 56). The HERVK-K(HML2) LTR has two
interferon-stimulated response elements (ISREs) and binding
sites for inflammatory transcription factors such as NFκB (57,
58). PcEV lacks such motifs and the absence of clear STAT1
binding sites suggests that STAT1 proteins do not directly
drive PcEV transcription. However, prediction of transcription
binding sites is complex and lowering the dissimilarity margin of
transcription binding site prediction from 5% to 15% allocates
the STAT3 binding sites in PcEV also to NFκB and STAT1.
STAT3 is activated at the protein level by IFN-1 (59) and binding
motifs in PcEV LTR for CEPBβ, whose RNA expression is
elevated by type-II IFN (60), were identified in the sequence
analyses. Alternatively, PcEV might be upregulated by accessory
proteins of exogenous retroviruses as HIV-1 Tat increases
HERVK(HML2) transcription (61, 62). Another possibility is
inflammation-induced demethylation of LTRs, where the HIV-
1 5′LTR undergoes demethylation following administration of
TNFα in vitro and LPS to transgenic mice harboring latent HIV
genomes in their lymphocytes (63, 64).
With regard to how PcEV might impact on innate immune
signaling pathways, two main mechanisms can be envisaged
(26). The first, via an exogenous route, implies binding of ERV
particles or glycoproteins to innate receptors such as TLRs,
as demonstrated in vitro where recombinant Env glycoprotein
from HERV-W triggers secretion of pro-inflammatory cytokines
via TLR4 in PBMC (65). The second, via an endogenous
route, is that ERV transcription and reverse transcription
may generate intermediate reaction products such as dsRNA,
possibly by transcription and hybridization of ERV sense and
antisense transcripts, and RNA:DNA hybrids generated during
reverse transcription detected by TLRs and cytosolic RIG-I-
like receptors, such as MDA5 (18–20). Only low PcEV RNA
levels were detected in plasma from around one-third of
SIV+ macaques, suggesting PcEV particles are unlikely to be
produced in large quantities. It seems plausible, however, that
PcEV might trigger induction mechanisms through released
viral components generated in a transient nature, supported
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FIGURE 7 | Tissue-specific relationship between cellular PcEV and cellular STAT1 RNA levels. Spleen, PBMC, thymus, and MLN compared for cellular PcEV and
STAT1 RNA levels, expressed as number of RNA copies/1,000 copies GAPDH (PLN sample size was too small). For each tissue, open circles represent naïve
macaques and closed circles SIV+ macaques. Large closed symbols represent SIV+ macaques in whose plasma PcEV RNA was detected. Statistical analysis of
SIV+ and naïve macaques are indicated (Spearman correlation analysis). Individual animals are labeled if they appear in more than one plot.
by the finding of full-length ORFs for the env gene in several
loci. In humans, ERV-encoded reverse transcriptase has been
suggested to reverse transcribe viral RNA intracellularly (66, 67).
In autoimmune TREX1-deficient mice, ERV DNA accumulates
in the cytoplasm, associated with inflammatory phenotypes (23)
which can be treated using RT inhibitors (68). Hence, the
correlation between PcEV and STAT1 expression in this in vivo
model requires further clarification.
One study limitation is that we restricted our analyses to data
from only a single time point. This might not reveal any delayed
correlations between PcEV, SIV, and STAT1 levels, especially
given differences in cellular and anatomical localization of SIV
(35). Cell sorting experiments to derive specific cell sub-sets
would help address this issue and refine analyses. Differences in
viral kinetics and tropism might also play a confounding role,
although all SIV strains studied, even the minimally attenuated
SIVmacC8, exhibit robust early replication kinetics in vivo
as determined by plasma viral RNA levels 10–14 days post-
infection.
To assess the relevance of the macaque as a model system,
similarities and differences between human and macaque ERVs
require consideration. Humans have a single ERV lineage that
has been replicating within the last few million years: HERV-
K (HML2). Early studies reported HERV-K(HML2) RNA in
plasma from HIV patients (53), but more recent studies failed
to reproduce this (13, 14). Evidence for low level PcEV RNA
was identified in the plasma of a proportion of SIV+ macaques.
Detection of retroviral RNA in plasma presumes some form
of protein protection, whether as fully or partially packaged
particles, so some macaques in the population may harbor a
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replication-competent PcEV locus. Although we did not find any
potentially replication-competent PcEV in the referencemacaque
genome sequences, this may reflect a combination of genome
assembly problems with the likelihood that such loci would be
unfixed in the macaque population, i.e., present only in the
genomes of some individual macaques (42). Evidence for at least
two unfixed PcEV loci was found. This phenomenon occurs
in HERV-K(HML2), where loci with full-length ORFs in all
genes are present only in some non-reference genomes (69, 70).
Replication-competent PcEV loci could also be generated by
recombination: in the mouse model, recombination between
replication-defective loci reconstituted replication-competent
loci with resulting infectious virions (71). Although macaques
might differ from humans in having as yet unrecovered
replication-competent PcEV loci, levels of cell-associated HERV-
K(HML2) transcription appear similar: ∼30 copies/1,000 copies
GAPDH in PBMC of non-acute HIV infection cases and
∼15 RNA/1,000 copies GAPDH in PBMC from uninfected
individuals (13).
Assuming SIV induces PcEV expression in vitro, knock-
down of PcEV transcription and individual sensors followed by
measurement of the IFN-1 response would determine whether
PcEV is involved in the IFN-1 response. The other two recently
active ERV lineages in the macaque, Chimpanzee Endogenous
Retrovirus (CERV), and Simian Endogenous type D Retrovirus
(SERV) (25), also require study since within both lineages
single examples of loci with full-length ORFs in all genes were
identified. Another important group of retroelements, Long
Interspersed Nuclear Elements (LINEs), also require scrutiny
because they, unlike ERVs, are known to be copying in the human
population (72) and potentially replication-competent loci have
been found in the macaque genome (73). LINEs have an entirely
intra-cellular replication cycle that would help is distinguishing
between endogenous and exogenous routes of innate triggering.
Considering several ERVs and LINEs together would provide
a wider perspective on whether retroelements are involved in
fundamental immune response induction.
In conclusion, the current study demonstrates that PcEV
retains transcriptional activity despite the apparent lack of
replication. Expression appears to be upregulated by acute
SIV infection and in some tissues a correlation exists between
the expression levels of PcEV and STAT1, the latter being
part of the IFN-1 cascade. The mechanistic processes at play
warrant detailed investigation to determine whether ERVs
are overlooked components of innate immune responses and
activation signaling mechanisms.
MATERIALS AND METHODS
Extraction and Alignment of PcEV Locus
Sequences
Bioinformatic analyses were performed using UCSC’s
Genome Browser website and its BLAT tool (74) on
the most recent reference genome sequence of the RM,
rheMac8 (Mmul_8.0.1). This assembly derives from short-
read Illumina whole genome sequencing (MacaM) (75)
with later closing of some gaps using long-read PacBio
sequencing of the same individual animal (comment in GenBank
accession GCA_000772875.3).
Sequences of loci were compared with those from an earlier
build of the RM genome, rheMac2 (76) (GenBank accession
GCA_000002255.2). This build is an earlier short-read whole
genome sequencing project largely from the same (female)
individual (ID 17573), with some sequencing of an unrelated
male used in finishing and to provide a Y chromosome.
Sequences were also compared to those of a CM, a closely related
species sharing a common ancestor only 0.91 (±0.11) million
years ago, which is more recent than the common ancestor of
all rhesus macaques (38). The reference genome sequence of
the CM, macFas5, appears to have been built independently
of the RM genome using a range of short-read technologies
(comment in GenBank accession GCA_000364345.1). The other
RM genome assembly available on the UCSC website, rheMac3,
is very fragmentary.
PcEV was described initially from the baboon (24)
(GenBank reference AF142988), erroneously referred to as
BaEV in an earlier analysis of the macaque genome (25) (see
Supplementary Information). This GenBank sequence was
used to locate and download the sequences of several PcEV loci
in the macaque using the UCSC Genome Browser. A multiple
alignment was then made of the downloaded sequences using
MEGA (77, 78) and a new consensus reference sequence built
with full-length ORFs in all genes (sequences from different loci
differed only by a few percent so alignments were unambiguous).
This reference was used to re-search the macaque genome.
Multiple alignments were made manually from downloaded
sequences and individual loci examined visually for full-length
ORFs and other motifs.
Previously published data on recently active macaque
ERVs lineages (11, 25) are presented here in more
detail (Figures S2–S4).
Prediction of Transcription Factor Motifs
A consensus PcEV LTR sequence was built based on an
alignment of LTR sequences from the loci displayed in Figure 1,
excluding the two much older loci, plus NC_022517 (36)
and AF142988 (24). This sequence was screened with the
ALGGEN-PROMO online tool (79, 80) for the presence of
putative binding sites for a range of transcription factors linked
to either inflammation or retroviral infection (43, 44). The
dissimilarity between query and binding site matrices from
the database was fixed at a threshold of 5%. The following
transcription factors and binding sites were selected for NHPs
only, with the accession number in the TRANSFAC public
database given in square brackets: AP1 [T00029]; NFI/CTF
[T00094]; C/EBPα [T00105]; NFY [T00150]; CREB [T00163];
cRel [T00168]; CTF [T00174]; GATA1 [T00306]; GATA2
[T00308]; GATA3[T00311]; GRα[T00337]; NF1[T00539];
NFAT1[T00550]; C/EBPβ[T00581]; C/EBP1[T00583];
NFkB[T00590]; NFkB1[T00593]; RelA [T00594]; POU2F1
[T00641]; Sp1 [T00759]; TBP [T00794]; YY1 [T00915]; STAT1α,
[T01492]; STAT3 [T01493]; STAT1β [T01573]; NFYA [T01804];
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GRβ [T01920]; NFAT2 [T01945]; NFAT1 [T01948]; STAT1
[T04759]; GR [T05076].
Dating the Integration of ERV Loci
Integrations were dated using the nucleotide divergence between
the two LTRs of the proviruses. These LTRs form the flanks of
the provirus (the complete integrated DNA form of a retrovirus)
and are identical at the time of integration, subsequently
accumulating substitutions at the host background rate. The
following equation was used to calculate locus age (81):
integration time= sequence distance between 5′ and 3′ LTR/(rate
in 5′ LTR+ rate in 3′ LTR).
Thus, estimated age= (a/b)/r∗2 where,
a= number of mismatches between the two LTRs,
b= length of the LTR,
r = estimated rate of nucleotide substitution.
Note, because substitutions will have occurred along the two
branches leading to the 5′ and the 3′ LTRs it is possible to
alternatively multiply the LTR length by two to reflect the effect
of this. The rate of nucleotide substitution was taken as 1.0 ×
10−9substitutions/nucleotide/year based on analyses of primate
ERV sequences (25). This value is about half the rate estimated
for mammals generally (82, 83) but is close to estimates for the
rate of neutral molecular evolution in Old Word Monkeys and
Apes (38).
For loci with no substitutions within their LTRs, the
probability (P0) of observing this if the locus had integrated
at time “age” can be found from the Poisson distribution with
P0 = e−λ where λ is the average number of events in the
time period. Thus, using the notation P0 =e(−2
∗b∗r∗age), the
probability of having no substitutions in the LTRs is just <0.5
at age 700,000 years.
Study Population and RNA Preparation
Plasma and cells were derived from acutely SIV-infected Indian
RM and CM challenged with different SIV isolates in historical
studies of SIV pathogenesis and vaccination (35, 48, 50, 84).
Total RNA was extracted from 140 µL to 1mL plasmas
using QiaAmp (Qiagen Ltd) according to the manufacturer’s
instruction. Plasmas obtained from CM were extracted from a
volume of 140 uL, the four RM plasmas were extracted from
1mL plasma. Each RNA preparation underwent a DNase step
to remove contaminant DNA and all qPCR samples were run
with an RT minus control, an essential step when working with
ERVs. Healthy human plasma contains about 1,000 genome
copies/mL, in the form of cell-free DNA (85), with many ERV
copies in every cell. By contrast, exogenous retroviruses have
only a single DNA copy in a small minority of PBMC (86),
so the danger of DNA contamination is greatly reduced. For
quantification of cell-associated transcripts, RNA was extracted
from frozen cells, washed once in PBS and lysed with guanidine
isothiocyanate (Sigma Ltd). Chloroform (200 µL) was added
followed by centrifugation at 13,000 rpm for 2min, aqueous
phase collected, 1 volume 100% ethanol added and samples
loaded onto an RNEasy silica column (Qiagen Ltd). Columns
were washed and RNA eluted according to the manufacturer’s
instruction to a final volume of 50 µL and quantitated using
nanodrop. Each RNA preparation was diluted to 10 ng/µL, and
50 ng (5 µL) added to each qPCR reaction.
Primers and Probe Sequences
Primer sequences for qPCR are shown below in 5′-3′ orientation.
PcEV primers were based on an alignment of PcEV pro-pol
sequences (Figure S5) designed to anneal to all loci. SIV primers
are based on conserved regions in gag (49) except for SIVsmE660
based on conserved LTR sequences (50). PcEV, GAPDH, and
STAT1 sequences were as follows:
PcEV: CCGTGTCTATCAAGCAATATCC (forward), GGC
AGAAGAGGAGTGTTCCAGG (reverse) and AACTCGGAG
TGTTGCGAC (probe).
GAPDH: GGCTGAGAACGGGAAGCTC (forward), AGG
GATCTCGCTCCTGGAA (reverse), and TCATCAATGGAA
GCCCCATCACCA (probe).
STAT1: CAATACCTCGCACAGTGGTTAGAAAA (forward)
and CGGATGGTGGCAAATGAAAC (reverse).
SIVsmE660: CTCCACGCTTGCTTGCTTAA (forward),
AGGGTCCTAACAGACCAGGG (reverse), TCCCATATCTCT
CCTAGYCGCCGC (probe).
Other SIVs: AGTGCCAACAGGCTCAGAAAA (forward),
TGCGTGAATGCACCAGATG (reverse) and TTAAAAAGC
CTTTATAATACTGTCTGCG (probe).
Plasmids and in vitro Transcription
pBluescript II SK+ (pBS, 3.0 kb) was from Stratagene Ltd (1
µg/µL). pBS-PcEV was derived separately by inserting a PcEV
amplicon into the multiple cloning site of a pBS vector using
ApaI (nt 604) restriction sites (GENEWIZ, Inc). pBS-PcEV
was linearized by HindIII restriction located 16nt downstream
of the PcEV sequence. Reaction mixes included 1 µg of
pBS-PcEV plasmid (0.2 µg/µL), 2 U/µL final concentration
of enzyme and 15 µL of water/enzyme buffer. Linearization
was at 37◦C for 1 h. In vitro transcription and purification
were carried using MAXIscript kit (Ambion Ltd) following
manufacturer’s instructions.
Standard Curves
PcEV transcripts were DNase-treated and 10-fold serial dilutions
made. PcEV copy number was determined by Poisson end-point
calculations, with Ct values obtained for each plasma sample
compared to the standard curve to estimate number of PcEV
copies per reaction (for 5 µL total RNA input). The number of
PcEV copies/mL for each plasma sample was determined taking
into account extraction starting volume. SIV standards used were
derived from a SIVmac251 plasma RNA reference series (49, 87).
For intracellular RT-PCR assessments, standards for GAPDHand
STAT1 were as previously described (35).
DNase Treatment of RNA Preparations
Removal of DNA contaminant was conducted using DNA-free
kit (Ambion Ltd). 5 µL of 10X DNAse buffer was added to
50 µL RNA preparation. 2 µL TURBO DNase was added and
incubated for 1 h at 37◦C. 10 µL Inactivation Reagents were
added and incubated for 5min with intermittent flicking of
tubes. Inactivation reagents were pelleted by centrifugation at
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10,000 g for 2min. Supernatant containing RNA was harvested,
assayed or stored at −80◦C for further analysis. In the absence
of DNAase treatment, similar copy numbers between RT+/RT-
reactions were noted: H17(RT+= 1.18E+04; RT−= 1.27E+04);
H18(RT+ = 7.06E+03; RT− = 9.12E+03); H19(RT+ =
2.39E+04; RT− = 2.37E+04); H20(RT+ = 6.96E+03; RT−
= 8.99E+03). Observed levels of DNA contamination are
consistent with theoretical expectations: assuming macaques
have similar levels of cell-free DNA in plasma, given at least 50
intact PcEV copies exist in eachmacaque cell, with an expectation
of at least 5× 104 DNA copies in plasma.
qPCR and qRT-PCR
Quantification of PcEV and SIV transcripts in plasma were
determined with 5 µL of DNase-treated RNA per qPCR reaction,
assayed in triplicate using RNAUltrasenseOne-StepQuantitative
RT-PCR kit (Invitrogen Ltd). For PcEV, qPCR reactions consisted
of 25.9 µL nuclease-free water, 1 µL forward and reverse primers
(5µM each, final concentration: 100 nM), 2.5 µL PcEV-specific
Taqman probe (10µM), 10 µL of 5X master mix, 0.1 µL
ROX reference dye, 2.5 µL Superscript III RT and Platinum
Taq polymerase enzyme mix. Cycling parameters were 48◦C
for 30min RT step, 95◦C for 5min, 95◦C for 15 s (40 cycles);
61◦C extension 1min. For SIV, mix contained 25.9 µL nuclease-
free water, 1 µL each forward and reverse primer (5µM each,
final concentration: 100 nM), 2.5 µL SIV-specific probe (10µM).
Cycling for 52◦C 60min RT step, 95◦C 10min, 95◦C for 30 s (40
cycles) and 61◦C extension for 90 s.
For quantification of cell-associated transcripts, each RNA
preparation was diluted to 10 ng/µL, so that 50 ng (5 µL) was
added in each qPCR reaction. For PcEV and SIV, qPCR was
conducted as stated above. For GAPDH, the mix contained 25.9
µL nuclease-free water, 1 µL each forward and reverse primer
(5µM each, final concentration: 100 nM), 2.5 µL GAPDH-
specific probe (10µM). Cycling parameters were 52◦C 60min RT
step, 95◦C, 10min, 40 cycles of 95◦C, 30 s (40 cycles) and 61◦C
extension for 90 s. For STAT1, the Power SYBR Green RNA-to-
Ct 1-step kit was used (Applied Biosystems Ltd). Mix consisted
of 15.6 µL nuclease-free water, 4 µL each forward and reverse
primer (10µM each, final concentration: 400 nM), 25 µL 2X
Master Mix (containing SYBR Green and polymerase) and 0.4
µL RT-enzyme mix. Cycling parameters were 48◦C 30min RT,
95◦C for 10min, 95◦C for 15 s (40 cycles) and 60◦C extension
for 1min. Melt curve was 95◦C for 15 s, 60◦C for 15 s and 95◦C
for 15 s. RNA preparations were confirmed to lack detectable
DNA by performing a parallel quantitative PCR lacking reverse
transcriptase for PcEV, SIV and GAPDH on all RNA extracts. In
the RNA Ultrasense system, enzyme mix was replaced by 0.2 µL
Platinum Taq polymerase (10 U/µL) (Invitrogen Ltd).
Statistical Analysis
GraphPad Prism version 6.01 was used for all statistical analyses.
The Mann-Whitney test was performed for comparing non-
paired samples in naïve vs. SIV+ groups; the Kruskal-Wallis
test was used to compare expression levels between macaques
infected with different strains of SIV. Since most datasets
had distributions that were significantly different from normal,
correlation coefficient r and p-values are presented from a
non-parametric Spearman test. Fisher’s Exact Test was used to
assess whether SIV is associated with PcEV in the plasma of
SIV+ animals.
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